• Sonuç bulunamadı

Chitotriosidase enzyme can be a negative acute phase protein in acuteheart failure unlike coronary artery diseases

N/A
N/A
Protected

Academic year: 2021

Share "Chitotriosidase enzyme can be a negative acute phase protein in acuteheart failure unlike coronary artery diseases"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Introduction: Heart Failure (HF) is a complex, neurohumoral and inflammatory syndrome. Recent studies show that proinflammatory cytokines contribute heart’s systolic or diastolic dysfunction causing cardiac depression. Chitotriosidase (CHIT), an enzyme released from active

macrophages, plays a role in many diseases involving inflammation. Therewithal, it has been observed that CHIT activity in plasma is significantly high in ischemic heart diseases with arterial inflammation. This thesis aims to figure out the role of CHIT in HF and the relationship between other cytokines. Method: 43 Newyork Heart Association (NYHA) class III/IV acute heart failure (AHF) patients who were hospitalized in the coronary intensive care unit (CICU), 48 chronic heart failure (CHF) patients and 45 healthy controls included in the study. All participants’ detailed echocardiography, doppler and tissue doppler measurements were performed and left ventricular ejection fractions (LVEF) were calculated by Simpson method. All participants’ plasma CHIT IL-1�, TNF�, IL-6, Hs-CRP and NT-proBNP levels were determined by ELISA method. Results: The lowest CHIT activity in plasma (527,876±323,04 ng/ml) is detected in AHF patients. It was observed that when LVEF of acute heart failure patients decrease their CHIT activity levels decrease as well. Also a negative correlation (p=0,038 and r=−0,32) occurred between CHIT activity levels and NYHA class levels in AHF patients. Conclusion: CHIT enzyme may play a role as a negative acute phase protein in AHF. Plasma CHIT value of AHF patients decreases when left ventricular systolic dysfunction increases and it is negatively correlated with NYHA values.

Referanslar

Benzer Belgeler

The Registry Focused on Very Early Presentation and Treatment in Emergency Department of Acute Heart Failure (REALITY-AHF) was the first prospective study to specifically focus on

BNP - plasma brain natriuretic peptide; CHF - chronic heart failure; CHFC - CHF control group; CHFT - CHF testing group; hsCRP - plasma high sensitive C-reactive protein; IL-1β

CV - cardiovascular; DD - diastolic dysfunction; EF - ejection fraction; HFpEF - heart failure with preserved ejection fraction; HFrEF - heart failure with reduced ejection

CS dilatation can result from increased blood flow due to abnormal venous drainage in the persistent left superior vena cava, total anomalous intra-cardiac pulmonary venous drainage,

The ability of albumin to bind to cobalt is reduced in patients with myocardial ischemia, providing the basis for the albumin cobalt-binding test for detecting IMA (5).. IMA is

High prevalence of renal dysfunction and its impact on out- come in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. Forman

Direct renin inhibition in addi- tion to or as an alternative to angiotensin converting enzyme inhibi- tion in patients with chronic systolic heart failure: rationale and design of

HR mean-mean heart rate, HR max -maximal heart rate, HR min-minimal heart rate, HR max -min-the difference value between HR max and HR min, HRPI - heart rate performance